The invention relates to the non-therapeutic, cosmetic use of at least one CB1 receptor antagonist as a whitening and/or anti-browning agent for keratin materials. The invention also relates to a CB1 receptor antagonist to be used in the treatment of hyperpigmentation disorders. The invention further relates to a non-therapeutic, cosmetic method for whitening the skin and/or the mucous membranes, which includes a step of orally delivering or topically applying, to the skin and/or to the mucous membranes, a CB1 receptor antagonist, and to a method for selecting a whitening and/or anti-browning agent for keratin materials.
USE OF A CB1 RECEPTOR ANTAGONIST AS A WHITENING AND/OR ANTI-BROWNING AGENT FOR KERATIN MATERIAL
MACCARRONE M
2013-01-01
Abstract
The invention relates to the non-therapeutic, cosmetic use of at least one CB1 receptor antagonist as a whitening and/or anti-browning agent for keratin materials. The invention also relates to a CB1 receptor antagonist to be used in the treatment of hyperpigmentation disorders. The invention further relates to a non-therapeutic, cosmetic method for whitening the skin and/or the mucous membranes, which includes a step of orally delivering or topically applying, to the skin and/or to the mucous membranes, a CB1 receptor antagonist, and to a method for selecting a whitening and/or anti-browning agent for keratin materials.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
